Literature DB >> 1309952

Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation.

L S Håvarstein1, I M Morgan, W Y Wong, P K Vogt.   

Abstract

The viral Jun protein (v-Jun) transforms chicken embryo fibroblasts (CEF) more effectively than its cellular counterpart (c-Jun). In certain cell types v-Jun is also a stronger transcriptional activator than c-Jun. These functional differences between v-Jun and c-Jun result from a deletion in v-Jun (referred to as "delta deletion") that seems to weaken the interaction of Jun with a negative cellular regulator molecule. These observations suggested that the oncogenicity of v-Jun may be due to an enhanced ability to activate transcription of target genes. To test this hypothesis, we constructed several deletions in the delta domain of chicken c-Jun and determined their transforming and transactivating properties. Surprisingly, we found an inverse correlation between the ability of the mutants to transform CEF and to transactivate the collagenase and transin promoters in CEF. In contrast, there was no significant effect of the delta mutations in c-Jun on transactivation in F9 murine embryonal carcinoma cells. The function of the delta region is therefore cell-type specific. The inverse correlation between transformation and transactivation in CEF suggests that the strong growth-promoting effect of v-Jun may be related to a failure to activate the transcription of growth attenuating genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309952      PMCID: PMC48290          DOI: 10.1073/pnas.89.2.618

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  c-rel activates but v-rel suppresses transcription from kappa B sites.

Authors:  J Inoue; L D Kerr; L J Ransone; E Bengal; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Trans-dominant negative mutants of Fos and Jun.

Authors:  L J Ransone; J Visvader; P Wamsley; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v- and c-Jun.

Authors:  V R Baichwal; R Tjian
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

Review 4.  Cross-coupling of AP-1 and intracellular hormone receptors.

Authors:  W W Lamph
Journal:  Cancer Cells       Date:  1991-05

5.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.

Authors:  B Binétruy; T Smeal; M Karin
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

6.  vRel is an inactive member of the Rel family of transcriptional activating proteins.

Authors:  P M Richardson; T D Gilmore
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

8.  Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex.

Authors:  M P Gaub; M Bellard; I Scheuer; P Chambon; P Sassone-Corsi
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

9.  Jun inhibits myogenic differentiation.

Authors:  H Y Su; T J Bos; F S Monteclaro; P K Vogt
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

10.  Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts.

Authors:  R P Ryseck; S I Hirai; M Yaniv; R Bravo
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

View more
  17 in total

1.  Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.

Authors:  S l Fu; I Bottoli; M Goller; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent.

Authors:  K Chida; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins.

Authors:  G D Spotts; S V Patel; Q Xiao; S R Hann
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera.

Authors:  U Kruse; J S Iacovoni; M E Goller; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  AP-1 factors play an important role in transformation induced by the v-rel oncogene.

Authors:  J Kralova; A S Liss; W Bargmann; H R Bose
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Specific activation in jun-transformed avian fibroblasts of a gene (bkj) related to the avian beta-keratin gene family.

Authors:  M Hartl; K Bister
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  A Jun-binding protein related to a putative tumor suppressor.

Authors:  F S Monteclaro; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Proliferative activation of quiescent Rat-1A cells by delta FosB.

Authors:  Y Nakabeppu; S Oda; M Sekiguchi
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

9.  Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.

Authors:  K L Hawker; A Pintzas; R F Hennigan; D A Gillespie; B W Ozanne
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62.

Authors:  S Gupta; A Seth; R J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.